Betty Eisner

Betty Eisner was a psychologist in the Los Angeles circle of early LSD researchers whose work helped establish psycholytic therapy as both a clinical practice and a cultural phenomenon. Working with Sidney Cohen and Oscar Janiger, she incorporated LSD into psychotherapy, reported substantial improvement among early patients, and described an experience beyond ordinary ego control as “unsanity.” Her career, as presented here, sits at a consequential boundary: the drug was being treated as a means of therapeutic access to the unconscious even as its advocates increasingly understood it in spiritual terms.

Identity and Introduction

Eisner had recently completed her doctorate at UCLA when, beginning in 1956, she joined Cohen in conducting LSD sessions with Bill Wilson, cofounder of Alcoholics Anonymous. Wilson had become interested in whether LSD could help recovering alcoholics undergo the kind of spiritual awakening he considered important to sobriety. He had heard of the Saskatchewan work through Humphry Osmond, who connected him with Cohen; Eisner joined Cohen in the sessions in Los Angeles. Her presence placed her in a widening network of researchers who shared methods and findings across North America and Europe, often in a cooperative rather than competitive spirit.

Eisner’s work belonged to a loose Los Angeles research hub that also included Janiger. Along with Cohen and Janiger, she began using LSD in weekly therapeutic sessions. The group’s approach emerged from a broader reconsideration of the early assumption that LSD produced a temporary psychosis. Cohen’s own 1955 experience had surprised him with tranquillity and a sense of insight rather than madness. Eisner later described his alternative conception of the state as “unsanity,” a condition beyond the ego’s control. The term gives a name to the conceptual shift underway in her circle: an altered state could be interpreted not as illness alone, but as a possible opening into a different mode of experience.

Therapeutic Practice and Results

In the Los Angeles group’s psycholytic treatment, doses were increased gradually from week to week. The aim was to help patients reach subconscious material, including repressed emotions and buried childhood memories. Eisner and her colleagues mainly treated neurotic patients, people with alcoholism, and people with minor personality disorders—patients who were articulate, functional, and able to engage in psychotherapy. The work retained the structure of ongoing therapy: LSD was introduced into repeated sessions rather than used as a single, isolated intervention.

The group also treated hundreds of painters, composers, and writers. Their rationale was that if creativity drew on the subconscious, LSD might broaden access to that source. Therapy and creative exploration thus occupied neighboring ground in the Los Angeles practice: the same proposed access to hidden mental material might serve patients seeking relief or artists seeking new possibilities.

Eisner and Cohen reported marked improvement in sixteen of their first twenty-two patients. A 1967 review of psycholytic-therapy papers published from 1953 through 1965 estimated success rates of 70 percent for anxiety neurosis, 62 percent for depression, and 42 percent for obsessive-compulsive disorder. These were striking figures, but the literature contained few, if any, attempts to reproduce the results in controlled trials. The findings established the confidence with which the group presented its practice, not definitive proof that LSD itself caused the reported benefits.

Public Profile and Professional Relationships

By the end of the 1950s, psycholytic LSD therapy had become routine in affluent parts of Los Angeles, including Beverly Hills. Some therapists charged more than five hundred dollars for a session while often obtaining the drug free from Sandoz. The practice attracted unusually favorable press, and celebrity testimonials helped carry it beyond clinical circles. Eisner was among the therapists whose offices became associated with transformative experiences; Cary Grant, who reported more than sixty sessions and described himself as “born again,” became one of the treatment’s most conspicuous public advocates. The publicity gave LSD therapy a reach that its limited controlled evidence could not independently secure.

Eisner’s relationship with Al Hubbard illustrates the strain within the research network. In 1955, Hubbard established the Commission for the Study of Creative Imagination, seeking to carry psychedelic work beyond medicine’s focus on illness. Eisner wrote Osmond to express discomfort with some of Hubbard’s representations. Osmond advised her to regard Hubbard as an explorer, not necessarily a detached or conventionally scientific investigator. The exchange captures a difference between respecting Hubbard’s energy and accepting his self-presentation: the researchers could value his role while remaining uneasy about his claims and methods.

Spiritual Interpretation and Legacy

Eisner did not confine her interest to the clinical model. She celebrated the introduction of the “transcendental into psychiatry” and developed an interest in paranormal phenomena. These commitments placed her among practitioners for whom psychedelic therapy could not be understood solely as a technical addition to conventional treatment. At the same time, the Los Angeles group’s weekly sessions remained recognizably therapeutic, directed toward memories, emotions, and psychological improvement. The two strands—clinical work and a willingness to entertain spiritual or paranormal interpretations—coexisted rather than resolving neatly into one account.

That coexistence became a point of professional vulnerability. Academic critics objected that investigators who took the drugs themselves, or became captivated by mystical states, could no longer be considered competent or unbiased. The emerging psychedelic model also challenged psychiatry more deeply than either the psychosis-based interpretation or psycholytic therapy, which could be fitted into psychoanalysis. It proposed a high-dose, conversion-like experience and required new ways of thinking about the roles of therapist and patient. Eisner’s celebration of transcendence exemplified why the approach could appear both promising and suspect to a profession increasingly committed to biochemical explanations and controlled trials.

The available account does not trace Eisner’s later career or establish the long-term outcome of her patients. It does show how her early practice helped give psycholytic therapy a concrete form: repeated sessions, increasing doses, therapeutic attention to buried material, and results that seemed compelling but remained weakly tested under controlled conditions. Her work and views also expose the central fault line of the period. LSD could be approached as a clinical instrument, a route into the unconscious, or an occasion for transcendence—and the disputes over which description counted as scientific were part of the history of the treatment itself.